56356-99-1

Basic information

• Product Name: 3-trifluoromethyl-4-chlorophenyldithiocarbamic acid
• Synonyms: 3-trifluoromethyl-4-chlorophenyldithiocarbamic acid
• CAS NO: 56356-99-1
• Molecular Weight: 271.715
• Mol File: 56356-99-1.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 3-trifluoromethyl-4-chlorophenyldithiocarbamic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-trifluoromethyl-4-chlorophenyldithiocarbamic acid(56356-99-1)
• EPA Substance Registry System: 3-trifluoromethyl-4-chlorophenyldithiocarbamic acid(56356-99-1)

Safety Data

• Hazardous Substances Data: 56356-99-1(Hazardous Substances Data)

Upstream product

• 320-51-4 4-chloro-3-trifluoromethyl-aniline 
• 75-15-0 carbon disulfide 

Downstream Products

• 446826-62-6 C₁₀H₅ClF₃NOS₂ 
• 1395063-35-0 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)thioureido)phenylthio)-N-cyclohexylpicolinamide 
• 1395063-39-4 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)thioureido)phenylthio)-N-cyclopropylpicolinamide 
• 1395063-41-8 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)thioureido)phenylthio)-N-ethylpicolinamide 
• 1246391-76-3 N-[4-chloro-3-(trifluoromethyl)phenyl]-[4-(N-methylformamide)(4-pyridylthio)phenyl]thiourea 
• 1395063-30-5 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-(2-(pyrrolidine-1-carbonyl)pyridin-4-ylthio)phenyl)thiourea 
• 1417341-26-4 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-(2-(pyrrolidine-1-carbonyl)pyridin-4-yloxy)phenyl)thiourea 
• 1412891-59-8 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-((2-(pyrrolidine-1-carbonyl)pyridin-4-yl)oxy)phenyl)thiourea 
• 1412891-58-7 4-(3-(3-(4-chloro-3-(trifluoromethyl)phenyl)thioureido)phenoxy)-N-cyclohexylpicolinamide 
• 1412891-57-6 4-(3-(3-(4-chloro-3-(trifluoromethyl)phenyl)thioureido)phenoxy)-N-cyclopropylpicolinamide 
• 1412891-56-5 4-(3-(3-(4-chloro-3-(trifluoromethyl)phenyl)thioureido)phenoxy)-N-ethylpicolinamide 
• 1412891-55-4 4-(3-(3-(4-chloro-3-(trifluoromethyl)phenyl)thioureido)phenoxy)-N-methylpicolinamide 
• 23163-86-2 1-chloro-4-isothiocyanato-2-(trifluoromethyl)benzene 

Relevant articles and documents

Design, synthesis and biological activities of sorafenib derivatives as antitumor agents

A series of novel sorafenib derivatives, 9a-w, was designed and synthesized in high yields using various substituted anilines, and their antiproliferative activities against HCT116, PC-3 and MDA-MB-231 cell lines were also evaluated and described. All compounds exhibited potent antiproliferative activity against HCT116 and PC-3 cells with IC50 = 2.8-52.0 and 2.2-45.6 μM; compounds 9p and 9q demonstrated competitive antiproliferative activities to sorafenib against all three cancer cell lines, the cytotoxicity of compound 9r is more potent than that of sorafenib. Compounds (9g, 9p, 9q and 9r) were chosen for further evaluation of the anti-angiogenesis activity, and showed the inhibition of sprout formation from aortic ring ex vivo. The structures of all the newly synthesized compounds were determined by 1H NMR, 13C NMR and HRMS.

The structure of the amine-containing thiourea compound and its preparation method and application

A disclosed thiourea compounds containing an arylamine structure comprises compounds of a general formula I and pharmaceutically acceptable salts. In the general formula I shown in the specification, R1 is selected from H, C1-C8 alkyl, halogens, -CF3, -OCF3, -NO2, -CN, R2O-, -SO2NH2, -NHSO2R3, -NR4R5, -CONR6R7, -COOR8, R9CO- and disubstituted and trisubstituted combinations thereof, R2, R3, R4, R5, R6, R7, R8 and R9 are respectively H or C1-C8 alkyl, L is selected from -NHR10, -NHOR11, -NR12R13, pyrrolidin-1-yl, 4-piperidyl and (4-methyl-1-piperazinyl)methylene, and R10, R11, R12 and R13 are respectively H, C1-C8 alkyl, cycloalkyl or aryl. The compounds have inhibiting effect on multiple tumor cell strains.

Thiourea and thioether derivatives of sorafenib: Synthesis, crystal structure, and antiproliferative activity

A series of novel sorafenib derivatives containing diaryl thiourea and thioether, 9a-u, was designed and synthesized, and their antiproliferative activities against HCT116 and MDA-MB-231 cell lines were also evaluated and described. Most compounds exhibited potent antiproliferative activity against HCT116 cells with IC50 = 1.8-80.4 μM. Compounds 9p, 9r, and 9s demonstrated competitive antiproliferative activities to sorafenib, against all two cancer cell lines. The structures of all the newly synthesized compounds were determined by 1H NMR, 13C NMR, and HRMS, and compound 9n was characterized by single-crystal X-ray diffraction. Primary structure-activity relationships (SAR) have also been established.